Data Foundry

Drug recalls 2023

ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0 — Class II drug recall D-0138-2023

Ongoing recall by Akorn, Inc., reported 2023-01-25, distributed nationwide. CGMP Deviations:

Recall numberD-0138-2023
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmAkorn, Inc., Gurnee, IL, United States
Recall initiated2022-10-13
Classified2023-01-13
Reported by FDA2023-01-25
DistributedNationwide (US)
Quantity1,109,600 tubes
Reason classescgmp
NDC17478-0070-35
Lot numbers0L58A, 1B21A, 1B31A, 1C44A, 1C57A, 1C58A, 1C58B, 1E13A, 1E24A, 1G60A, 1G62A, 1G63A, 1J21A, 1J34B, 1J40A, 1K74A, 1L93A, 1L96A, 1L96B, 1M24A, 1M25A, 1M31A, 2A02A, 2A10A, 2C07A, 2D47A, 2E50A, 2E51A
Expiration dates2022-10-31, 2023-01-31, 2023-02-28, 2023-04-30, 2023-06-30, 2023-08-31, 2023-09-30, 2023-10-31, 2023-11-30, 2023-12-31, 2024-02-29, 2024-03-31, 2024-04-30

Product

ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5%, Net Weight: 3.5g (1/8 oz) per tube, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-070-35

Reason for recall

CGMP Deviations:

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0138-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.